Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,087 across all filing types
Latest filing 2023-06-22 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure filed by Citadel Group regarding their interests and dealings in the securities of Horizon Therapeutics PLC. This is a standard regulatory disclosure required under the Irish Takeover Panel Act, 1997, specifically for persons with interests in relevant securities representing 1% or more during a takeover or merger process. While it relates to M&A activity, it is a specific regulatory disclosure of shareholding positions and dealings rather than a general M&A announcement (TAR). Given the specific nature of the form and the regulatory requirement for such disclosures, it falls under the 'Regulatory Filings' (RNS) category as it is a mandatory disclosure filed via a Regulatory Information Service.
2023-06-22 English
Form 8.3 - Network International Holdings Plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivative positions, and recent dealings. Since this is a specific regulatory disclosure form related to takeover activity and does not fit into the other categories like M&A (which usually refers to the company's own announcements) or Major Shareholding Notifications (which are typically for the company's own equity structure), it is classified as a Regulatory Filing (RNS).
2023-06-22 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests, short positions, and dealings in the securities of Horizon Therapeutics PLC by Citadel Group. This type of document is a specific regulatory disclosure regarding major shareholding and derivative positions during a takeover period, which falls under the 'Major Shareholding Notification' category.
2023-06-21 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a mandatory regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Network International Holdings PLC). This type of disclosure is a specific regulatory requirement for market transparency during M&A activity and does not fit into the other categories like M&A (TAR) or Shareholding Notification (MRQ) as it is a specific regulatory form for market surveillance.
2023-06-21 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests and short positions of Citadel Group in the securities of Horizon Therapeutics PLC. This type of filing is specifically used to notify the market of significant shareholding positions or changes in positions during a takeover or merger process. It is not a report publication announcement, but rather the primary disclosure document itself, falling under the category of Major Shareholding Notification.
2023-06-20 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more. This type of disclosure is a specific regulatory requirement for market surveillance and does not fit into categories like Annual Reports, Earnings Releases, or M&A activity announcements (though it relates to an offer, it is a disclosure of holdings, not the M&A document itself). Therefore, it is classified as a Regulatory Filing (RNS).
2023-06-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.